Next Article in Journal
Previous Article in Journal
Int. J. Mol. Sci. 2012, 13(2), 1444-1460; doi:10.3390/ijms13021444
Article

Elevated Peripheral Blood Plasma Concentrations of Tie-2 and Angiopoietin 2 in Patients with Neuroendocrine Tumors

1,†
, 1,†
, 2
, 1
, 1
, 2
 and 1,*
Received: 9 January 2012; in revised form: 19 January 2012 / Accepted: 19 January 2012 / Published: 31 January 2012
(This article belongs to the Section Molecular Pathology)
View Full-Text   |   Download PDF [729 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Background: Gastro-entero-pancreatic/neuroendocrine (NET) tumors are highly vascularized neoplasms. However, our knowledge concerning circulating levels of the angiogenic factors in NET patients still remains insufficient. Methods: The aim of this study was to measure plasma concentrations of VEGF, angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2), soluble Tie-2, endostatin, osteopontin (OPN) and chromogranin A (CgA) in 36 NET patients and 16 controls. Results: Only the plasma concentrations of Tie-2 and CgA were higher in NET patients as compared to controls. These levels were within the reference range in controls; however one control demonstrated slightly elevated Tie-2 and 4 elevated CgA. Similarly, in the subgroup of patients with carcinoid syndrome, only Tie-2 and CgA concentrations were higher than those in patients with non-functioning NETs. In turn, in the subgroup of metastatic patients, only Ang-2 levels were higher than in those with localized disease. A positive correlation was found between Ang-2 and Tie-2 levels in metastatic patients and between Ang-1 and Tie-2 in localized NETs. Conclusions: The plasma concentration of Tie-2 is proposed as an additional marker for NET patients and seems to be similarly effective as the currently used CgA level. Moreover, higher plasma levels of Ang-2 together with the positive correlation between Ang-2 and Tie-2 levels in metastatic subjects, implies that cases with a Tie-2 level above the upper limits, together with higher level of Ang-2 seem to be highly predictive of metastases.
Keywords: angiogenic factors; NET patients; Ang-1; Ang-2, Tie-2 angiogenic factors; NET patients; Ang-1; Ang-2, Tie-2
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Melen-Mucha, G.; Niedziela, A.; Mucha, S.; Motylewska, E.; Lawnicka, H.; Komorowski, J.; Stepien, H. Elevated Peripheral Blood Plasma Concentrations of Tie-2 and Angiopoietin 2 in Patients with Neuroendocrine Tumors. Int. J. Mol. Sci. 2012, 13, 1444-1460.

AMA Style

Melen-Mucha G, Niedziela A, Mucha S, Motylewska E, Lawnicka H, Komorowski J, Stepien H. Elevated Peripheral Blood Plasma Concentrations of Tie-2 and Angiopoietin 2 in Patients with Neuroendocrine Tumors. International Journal of Molecular Sciences. 2012; 13(2):1444-1460.

Chicago/Turabian Style

Melen-Mucha, Gabriela; Niedziela, Agata; Mucha, Slawomir; Motylewska, Ewelina; Lawnicka, Hanna; Komorowski, Jan; Stepien, Henryk. 2012. "Elevated Peripheral Blood Plasma Concentrations of Tie-2 and Angiopoietin 2 in Patients with Neuroendocrine Tumors." Int. J. Mol. Sci. 13, no. 2: 1444-1460.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert